Urgent.News

What's breaking now, across hundreds of outlets.

Finance & Markets

CeriBell: 3 Key Takeaways for Long-Term Investors

Key PointsFull-year 2026 revenue guidance rose to $115 million to $117 million.

CeriBell (CBLL) reported its third-quarter 2026 earnings on November 3, 2026, announcing full-year revenue guidance of $115 million to $117 million. The company's gross margins stood at 90%, and its hardware capabilities are expanding, providing operating leverage as it enters untapped market opportunities such as delirium monitoring.

Key takeaways for long-term investors include CeriBell's introduction of a delirium monitoring tool as a fee-free software update, which will drive revenue through increased usage of single-use headbands, and the launch of Omni, a hardware platform that merges quick bedside EEG brain monitoring with traditional multi-day continuous recording.

The company's high gross margins and strong balance sheet provide confidence in achieving self-funded profitability.

Brief written by urgent.news; may contain errors — check the original.

Sources: fool.com · nasdaq.com

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at nasdaq.com →

Report a problem with this story

More in Finance & Markets

More from Sunday 22 November →